Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Stockholders' Equity (Deficit)

v3.25.1
Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning balance at Dec. 31, 2022 $ 21,035,401 $ 4,224 $ 68,798,301 $ 104,718 $ (47,871,842)
Beginning balance, Shares at Dec. 31, 2022   4,224,294      
Stock-based compensation expense 500,148   500,148    
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs, Shares   1,961,986      
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs 8,575,097 $ 1,962 8,573,135    
Other comprehensive income (103,841)     (103,841)  
Net Income (Loss) (19,028,883)       (19,028,883)
Ending balance at Dec. 31, 2023 $ 10,977,922 $ 6,186 77,871,584 877 (66,900,725)
Ending balance, Shares at Dec. 31, 2023 6,186,280 6,186,280      
Stock-based compensation expense $ 8,140,617   8,140,617    
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs, Shares   63,176,159      
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs 103,305,752 $ 63,176 103,242,576    
Other comprehensive income (38,125)     (38,125) 0
Net Income (Loss) (27,519,886)       (27,519,886)
Ending balance at Dec. 31, 2024 $ 94,866,280 $ 69,362 $ 189,254,777 $ (37,248) $ (94,420,611)
Ending balance, Shares at Dec. 31, 2024 69,362,439 69,362,439